Estrogen, HDL, and Coronary Heart Disease in Women

Trial Profile

Estrogen, HDL, and Coronary Heart Disease in Women

Phase of Trial: Phase III

Latest Information Update: 23 Apr 2016

At a glance

  • Drugs Conjugated estrogens (Primary) ; Estradiol congeners; Hormonal replacements; Lipids; Medroxyprogesterone; Progesterone congeners
  • Indications Coronary arteriosclerosis; Menopausal syndrome
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms ERA
  • Most Recent Events

    • 01 Jul 2009 Results were published in Atherosclerosis.
    • 13 Feb 2008 The expected completion date for this trial is now 1 Feb 2007.
    • 24 Jan 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top